Quick Answer
DEXCOM INC reported Shares Outstanding of 384.80 million shares for fiscal year 2025.
DEXCOM INC Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 384.80M | -1.5% |
| 2024 | 390.70M | +1.4% |
| 2023 | 385.40M | -0.2% |
| 2022 | 386.30M | -0.4% |
| 2021 | 388.00M | +303.7% |
| 2020 | 96.10M | +4.9% |
| 2019 | 91.60M | +1.8% |
| 2018 | 90.00M | +3.4% |
| 2017 | 87.00M | +2.8% |
| 2016 | 84.60M | +3.5% |
| 2015 | 81.70M | +5.7% |
| 2014 | 77.30M | +6.6% |
| 2013 | 72.50M | +4.3% |
| 2012 | 69.50M | +3.0% |
| 2011 | 67.50M | +8.7% |
| 2010 | 62.08M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 390.00M | -0.2% | -0.6% |
| June 30, 2025 | 392.20M | -2.1% | +0.0% |
| March 31, 2025 | 392.10M | -1.0% | +0.4% |
| December 31, 2024 | 390.70M | +1.4% | +0.0% |
| September 30, 2024 | 390.60M | +1.1% | -2.5% |
| June 30, 2024 | 400.70M | +3.8% | +1.2% |
| March 31, 2024 | 396.10M | +2.2% | +2.8% |
| December 31, 2023 | 385.40M | -0.2% | -0.3% |
- DEXCOM INC showed a decrease of -1.5% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, DEXCOM INC’s shares outstanding has grown by 519.9% (from 62.08 million shares to 384.80 million shares).
- The most recent figure is from DEXCOM INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: